(TKAI) - Earnings & Price History

TKAI: - 5.4864, $0.00M, 4.85 (757.52%)

Sector: Healthcare - Industry: Biotechnology

Tokai Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies for prostate cancer and other hormonally-driven diseases. Its lead drug candidate is galeterone, an oral small molecule that is in various clinical trials for the treatment of patients with metastatic castration-resistant prostate cancer. The companys androgen receptor degradation (ARDA) drug discovery program is focused on identifying and developing compounds for ARDA activity. Tokai Pharmaceuticals, Inc. was founded in 2004 and is based in Boston, Massachusetts.Key Statistics

Past TKAI reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2016-08-12
2016-08-111.141.151.161.121.180.87%-1.72%-0.87%297.18K
2016-08-101.151.121.121.121.22.68%2.68%398.15K
2016-05-10-0.577.197.196.837.24-2.64%-2.64%49.30K
2016-03-10-0.475.965.935.935.776.150.51%0.51%62.15K
2015-11-10-0.511.6411.1811.2411.0611.90.54%▲3.56%4.11%86.85K
2015-05-12-0.3111.7411.0711.0512.096.05%307.24K

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades